Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lancet [Lancet] NLMUID: 2985213R"" wg kryterium: JN


Tytuł :
Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
Autorzy :
Cameron ST; Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh, UK; Chalmers Sexual and Reproductive Health, NHS Lothian, Edinburgh, UK. Electronic address: .
Glasier A; Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh, UK.
McDaid L; Institute for Social Science Research, The University of Queensland, Brisbane, QLD, Australia; MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
Radley A; Directorate of Public Health, NHS Tayside, Dundee, UK; Division of Cardiovascular Medicines and Diabetes, Ninewells Hospital and Medical School, Dundee, UK.
Baraitser P; Department of Sexual Health, King's College Hospital NHS Foundation Trust, London, UK.
Stephenson J; Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
Gilson R; Institute for Global Health, University College London, London, UK.
Battison C; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Cowle K; Boots UK, Edinburgh, UK.
Forrest M; Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Goulao B; Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Johnstone A; Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh, UK.
Morelli A; Department of Sexual Health, King's College Hospital NHS Foundation Trust, London, UK.
Patterson S; MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
McDonald A; Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Vadiveloo T; Health Services Research Unit, University of Aberdeen, Aberdeen, UK.
Norrie J; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1585-1594.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Renal cancer with extensive level IV intracardiac tumour thrombus removed by robot.
Autorzy :
Gill IS; Catherine & Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: .
Cacciamani GE; Catherine & Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Duddalwar V; Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Thangathurai D; Department of Anesthesiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Cunningham M; Department of Cardiovascular Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. e88.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Breast cancer radiation therapy - Authors' reply.
Autorzy :
Brunt AM; School of Medicine, University of Keele, Staffordshire ST5 5BG, UK. Electronic address: .
Haviland JS; Institute of Cancer Research, Sutton, London, UK.
Wheatley DA; Royal Cornwall Hospital, Treliske, Truro, UK.
Yarnold JR; Institute of Cancer Research, Sutton, London, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1559-1560.
Typ publikacji :
Letter; Comment
MeSH Terms :
Breast Neoplasms*/radiotherapy
Breast ; Humans ; Research
Opinia redakcyjna
Tytuł :
Bridge-It trial-a step towards better contraception services.
Autorzy :
Marston C; DEPTH Research Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: .
Sowemimo A; Midlands Partnership NHS Foundation Trust, Haymarket Health, Leicester Integrated Sexual and Reproductive Health, Leicester, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1536-1537.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Eplerenone for chronic central serous chorioretinopathy - Authors' reply.
Autorzy :
Lotery A; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Electronic address: .
O'Connell A; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Harris RA; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Sivaprasad S; NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital National Health Service Foundation Trust, London, UK.
Reeves BC; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1557-1558.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Serous Chorioretinopathy*/diagnosis
Central Serous Chorioretinopathy*/drug therapy
Eplerenone ; Humans ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Spironolactone/therapeutic use
Opinia redakcyjna
Tytuł :
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Autorzy :
Grosicki S; Medical University of Silesia, Katowice, Poland. Electronic address: .
Simonova M; Institute of Blood Pathology and Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
Spicka I; Charles University and General Hospital, Prague, Czech Republic.
Pour L; Clinic of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Kriachok I; National Cancer Institute Ukraine, Kiev, Ukraine.
Gavriatopoulou M; Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Pylypenko H; Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine.
Auner HW; Imperial College London, London, UK.
Leleu X; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France.
Doronin V; City Clinical Hospital No. 40, Moscow, Russia.
Usenko G; City Clinical Hospital 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine.
Bahlis NJ; Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada.
Hajek R; Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Benjamin R; Kings College NHS Foundation Trust, Kings College London, London, UK.
Dolai TK; Nil Ratan Sircar Medical College and Hospital, Kolkata, India.
Sinha DK; State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, India.
Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Garg M; University Hospitals of Leicester NHS Trust, Leicester, UK.
Gironella M; Vall d'Hebron University Hospital, Barcelona, Spain.
Jurczyszyn A; Department of Hematology, Jagiellonian University Medical College, Kraków, Poland.
Robak P; Department of Hematology, Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland.
Galli M; Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Wallington-Beddoe C; Flinders Medical Centre and Flinders University, Adelaide, SA, Australia.
Radinoff A; University Hospital 'St Ivan Rilski' EAD, Sofia, Bulgaria.
Salogub G; Chemotherapy of Oncology Diseases-Bone Marrow Transplantation Department 1, Almazov National Medical Research Centre, Ministry of Health of Russia, St Petersburg, Russia.
Stevens DA; Norton Cancer Institute, St Matthews Campus, Louisville, KY, USA.
Basu S; New Cross Hospital, Royal Wolverhampton NHS Trust and University of Wolverhampton, Wolverhampton, UK.
Liberati AM; Oncohematology Hospital S Maria Terni, University of Perugia, Terni, Italy.
Quach H; University of Melbourne, St Vincent's Hospital, Melbourne, VIC, Australia.
Goranova-Marinova VS; University Hospital 'Sv Georgi' EAD, Clinic of Clinical Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria.
Bila J; Clinic for Hematology, Clinical Centre of Serbia, Belgrade, Serbia.
Katodritou E; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece.
Oliynyk H; Department of Hematology, Vinnytsia M I Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine.
Korenkova S; Bone Marrow Transplantation Department, Kyiv Bone Marrow Transplantation Center, Kyiv, Ukraine.
Kumar J; Tata Medical Center, Kolkata, India.
Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Moreau P; University Hospital, Hotel-Dieu, Nantes, France.
Levy M; Baylor University Medical Center, Dallas, TX, USA.
White D; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada.
Gatt ME; Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Facon T; CHU Lille Service des Maladies du Sang F-59000, Lille, France.
Mateos MV; Hospital Universitario de Salamanca, Salamanca, Spain.
Cavo M; Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy.
Reece D; University Health Network-Princess Margaret Cancer Centre, Toronto, ON, Canada.
Anderson LD Jr; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Saint-Martin JR; Karyopharm Therapeutics, Newton, MA, USA.
Jeha J; Karyopharm Therapeutics, Newton, MA, USA.
Joshi AA; Karyopharm Therapeutics, Newton, MA, USA.
Chai Y; Karyopharm Therapeutics, Newton, MA, USA.
Li L; Karyopharm Therapeutics, Newton, MA, USA.
Peddagali V; Karyopharm Therapeutics, Newton, MA, USA.
Arazy M; Karyopharm Therapeutics, Newton, MA, USA.
Shah J; Karyopharm Therapeutics, Newton, MA, USA.
Shacham S; Karyopharm Therapeutics, Newton, MA, USA.
Kauffman MG; Karyopharm Therapeutics, Newton, MA, USA.
Dimopoulos MA; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA.
Delimpasi S; General Hospital Evangelismos, Athens, Greece.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1563-1573.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Conflicts of interest should be declared.
Autorzy :
Daube M; Faculty of Health Sciences, Curtin University, U1987 Perth, WA, Australia. Electronic address: .
Swanson M; Australian Council on Smoking and Health, Subiaco, WA, Australia.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1561-1562.
Typ publikacji :
Letter; Comment
MeSH Terms :
Conflict of Interest*
Smoking Cessation*
China
Opinia redakcyjna
Tytuł :
Eplerenone for chronic central serous chorioretinopathy.
Autorzy :
Sacconi R; Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan 20132, Italy.
Borrelli E; Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan 20132, Italy.
Querques G; Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan 20132, Italy. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1556.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Serous Chorioretinopathy*/diagnosis
Central Serous Chorioretinopathy*/drug therapy
Double-Blind Method ; Eplerenone ; Humans ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Spironolactone/therapeutic use
Opinia redakcyjna
Tytuł :
Breast cancer radiation therapy.
Autorzy :
Offersen BV; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus 8200, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus 8200, Denmark. Electronic address: .
Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus 8200, Denmark.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1558.
Typ publikacji :
Letter; Comment
MeSH Terms :
Breast Neoplasms*/radiotherapy
Breast ; Disease Progression ; Humans ; Radiation Dose Hypofractionation
Opinia redakcyjna
Tytuł :
Eplerenone for chronic central serous chorioretinopathy.
Autorzy :
Stanescu-Segall D; Département d'Ophtlalmologie, Centre Hospitalier Universitaire Piite Salpétrière, Paris 75013, France. Electronic address: .
Touhami S; Département d'Ophtlalmologie, Centre Hospitalier Universitaire Piite Salpétrière, Paris 75013, France.
Bodaghi B; Département d'Ophtlalmologie, Centre Hospitalier Universitaire Piite Salpétrière, Paris 75013, France.
LeHoang P; Département d'Ophtlalmologie, Centre Hospitalier Universitaire Piite Salpétrière, Paris 75013, France.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1556-1557.
Typ publikacji :
Letter; Comment
MeSH Terms :
Central Serous Chorioretinopathy*/diagnosis
Central Serous Chorioretinopathy*/drug therapy
Double-Blind Method ; Eplerenone ; Humans ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Spironolactone/therapeutic use
Opinia redakcyjna
Tytuł :
Improving global surveillance of gender-based violence.
Autorzy :
Chandan JS; Institute of Applied Health, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK; Warwick Medical School, University of Warwick, Warwick, UK. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1562.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Lessons from The Lancet Low Back Pain Series media strategy.
Autorzy :
O'Keeffe M; Institute for Musculoskeletal Health and Faculty of Medicine and Health, School of Public Health, University of Sydney, NSW 2050, Australia. Electronic address: .
Maher CG; Institute for Musculoskeletal Health and Faculty of Medicine and Health, School of Public Health, University of Sydney, NSW 2050, Australia.
Rozbroj T; Monash Department of Clinical Epidemiology, Cabrini Institute, and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Schoene M; The BackLetter Lippincott, Newbury, MA, USA.
Buchbinder R; Monash Department of Clinical Epidemiology, Cabrini Institute, and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1560-1561.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Analysing how sex and gender interact.
Autorzy :
Stefanick ML; Stanford Prevention Research Center, Department of Medicine, Department of Obstetrics and Gynecology, and Women's Health and Sex Differences in Medicine Center, Stanford University, Stanford, CA, USA.
Schiebinger L; History of Science and EU/US Gendered Innovations in Science, Health and Medicine, Engineering and Environment, Stanford University, Stanford, CA 94305-2024, USA. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1553-1554.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Breast cancer radiation therapy.
Autorzy :
McClelland S 3rd; Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1559.
Typ publikacji :
Letter; Comment
MeSH Terms :
Breast Neoplasms*/radiotherapy
Breast ; Disease Progression ; Humans ; Radiation Dose Hypofractionation
Opinia redakcyjna
Tytuł :
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Autorzy :
Thomalla G; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. Electronic address: .
Boutitie F; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France; Université Lyon 1, Villeurbanne, France; Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne, France.
Ma H; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia.
Koga M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Ringleb P; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Schwamm LH; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Wu O; Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
Bendszus M; Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.
Bladin CF; Department of Neurosciences, Eastern Health and Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia.
Campbell BCV; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Cheng B; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Churilov L; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Ebinger M; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany; Klinik für Neurologie Medical Park Berlin Humboldtmühle, Berlin, Germany.
Endres M; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany; Klinik und Hochschulambulanz für Neurologie, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Centre of Cardiovascular Research, Berlin, Germany; German Center of Neurodegenerative Diseases, Berlin, Germany.
Fiebach JB; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Fukuda-Doi M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Data Science, National Cerebral and Cardiovascular Center, Suita, Japan.
Inoue M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Kleinig TJ; Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Latour LL; Acute Cerebrovascular Diagnostics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Lemmens R; Department of Neurosciences, Experimental Neurology, KU Leuven, University of Leuven, Leuven, Belgium; VIB Center for Brain and Disease Research Leuven, Belgium; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
Levi CR; The Department of Neurology, Priority Research Centre for Brain and Mental Health Research, John Hunter Hospital, University of Newcastle, Newcastle, NSW, Australia.
Leys D; Université de Lille, Inserm U1171, Lille, France.
Miwa K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Molina CA; Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Muir KW; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
Nighoghossian N; Department of Stroke Medicine, Université Claude Bernard Lyon 1, CarMeN Laboratory, INSERM U1060/INRA 1397, Lyon, France.
Parsons MW; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Pedraza S; Department of Radiology, Institut de Diagnòstic per la Imatge, Hospital Dr Josep Trueta, Institut d'Investigació Biomèdica de Girona, Girona, Spain.
Schellinger PD; Universitätsklinik für Neurologie, Mühlenkreiskliniken, Johannes Wesling Klinikum Minden, Universitätsklinikum der Ruhr-Universität Bochum, Minden, Germany.
Schwab S; Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Simonsen CZ; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Song SS; Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Thijs V; Florey Institute of Neuroscience and Mental Health, Heidelberg, VIC, Australia; Department of Neurology, Austin Health, Heidelberg, VIC, Australia.
Toni D; Department of Human Neurosciences, University of Rome 'La Sapienza', Rome, Italy.
Hsu CY; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Wahlgren N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Yamamoto H; Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, Suita, Japan.
Yassi N; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Yoshimura S; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Warach S; Dell Medical School, University of Texas at Austin, Austin, TX, USA.
Hacke W; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Toyoda K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Donnan GA; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Davis SM; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Gerloff C; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Corporate Authors :
Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1574-1584. Date of Electronic Publication: 2020 Nov 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Announcing the Lancet Commission on stigma and discrimination in mental health.
Autorzy :
Thornicroft G; Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK. Electronic address: .
Sunkel C; Global Mental Health Peer Network, Johannesburg, South Africa.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1543-1544. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies